companies / chroniclebio-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 2,225,0002.2M | ○ |
|---|---|---|
| founded | 2021 | |
| hq | WEST VALLEY, UT | |
| industry | unknown | |
| stage | null |
ChronicleBio uses large-scale human-data analysis to identify drug targets and develop disease-defining medicines. It serves pharma partners and patients with diseases that lack precise treatments. The platform turns multi-omic human data into validated targets, prioritizing biology grounded in real patient evidence rather than animal models.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-10-15 | Funding round | 2,225,0002.2M | null | ○ |
Express, Google Cloud CDN, Google Cloud Load Balancing, Google Cloud, Node.js, React
| fact | status | src |
|---|---|---|
| Funding round, $2.2M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-25latest_round: seed, $2.2M, 2025-10-15 → Funding round, $2.2M, 2025-10-15, ○ 2026-05-05 | latest_round | seed, $2.2M, 2025-10-15 → Funding round, $2.2M, 2025-10-15 | ○ 2026-05-05 |
Records begin 2026-09-24. all_changes